Please assess the completion status of the following clinical trial:

Trial Title: Activity and Balanced Eating to Reduce Comorbidities and Symptoms of MS

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: SINGLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Relapsing-Remitting MS~* On disease modifying treatment for 6 months~* No relapse within the previous 30 days~* BMI 25-55 kg/m2~* Self-identify as not currently meeting recommendations for healthy diet and physical activity~* Ambulatory with or without assistance~* Reliable access to the internet via computer or smartphone~* Responsible for their personal food preparation or have input into the food prepared for them~* Score indicating low cognitive functioning on the Telephone Interview for Cognitive Status assessment~Exclusion Criteria:~* Physician does not approve participation~* Use of the following diabetes medications: Acetohexamide, Chlorpropamide (Diabinese), Tolbutamide (Orinase, Tol-Tab), Tolazamide (Tolinase), Glipizide (Glucotrol, Glucotrol XL, Metaglip), Glyburide (Micronase, DiaBeta, Glynase, Glucovance), Glimepiride (Amaryl), Humalog or lispro, Novolog or aspart, Apidra or glulisine, Regular (R) humulin or novolin, Velosulin (for use in the insulin pump), NPH (N), Lente (L), Ultralente (U), Lantus, Levemir or detemir, Humulin 70/30, Novolin 70/30, Novolog 70/30, Humulin 50/50, or Humalog mix 75/25~* Already on a specific diet meant to improve health~* Heart attack, stroke, or heart bypass surgery less than 6 months ago~* Pulmonary disease, cardiovascular disease or renal failure less than 6 months ago~* Smoking~* Cancer, HIV or liver/kidney disease~* Inability to travel to Lakeshore for testing

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: 65 Years
- Healthy Volunteers: f

Study Arms:
- BIPAMS (Type: ACTIVE_COMPARATOR): All participants will receive the standard BIPAMS intervention for the first 8 weeks of the trial.Those in the BIPAMS group will continue receiving the established BIPAMS intervention for the remainder of the trial.
- BIPAMS + Diet (Type: EXPERIMENTAL): All participants will receive the standard BIPAMS intervention for the first 8 weeks of the trial.Those in the BIPAMS+Diet arm will begin receiving dietary materials in week 9.

Based on this trial design, predict the completion outcome and termination type (if applicable).